A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma (Q37325331)
Jump to navigation
Jump to search
scientific article published on 27 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma |
scientific article published on 27 August 2013 |
Statements
1 reference
A phase I study of an agonist CD40 monoclonal antibody (CP-870,893) in combination with gemcitabine in patients with advanced pancreatic ductal adenocarcinoma (English)
1 reference
Abass Alavi
1 reference
Drew A Torigian
1 reference
E Gabriela Chiorean
1 reference
Alex Brothers
1 reference
Weijing Sun
1 reference
Ursina R Teitelbaum
1 reference
Robert H Vonderheide
1 reference
Peter J O'Dwyer
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference